Abstract
The zebrafish (Danio rerio) has been increasingly recognized as a promising animal model for cancer research. Zebrafish tumors can be generated by treatment with chemical carcinogens or by genetic approaches. The liver has been a main target organ for tumorigenesis after carcinogen treatment while many other tissue-specific tumors have been generated by tissue-specific expression of proven oncogenes. We have used both the chemical and transgenic approaches to generate liver tumors. By comparative analyses of transcriptome profiles between human liver tumors and carcinogen-induced zebrafish liver tumors, we have demonstrated a remarkable similarity in the molecular hallmarks during liver tumorigenesis between humans and zebrafish, thus validating the zebrafish model for human cancer studies. Recently, we have also generated stable transgenic zebrafish lines overexpressing the c-Myc and kras V12 in the liver using two different inducible gene expression systems. In both cases, we found that tumors can be reproducibly induced in the liver, and histopathological examination confirmed the production of liver neoplasia including heptocellular carcinoma. Thus, we have successfully established transgenic zebrafish models for liver cancers and these models will be further characterized in order to understand the molecular and genetic mechanisms of liver carcinogenesis as well as for anti-cancer drug discovery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amsterdam A, Sadler KC, Lai K et al (2004) Many ribosomal protein genes are cancer genes in Zebrafish. PLoS Biol 2:690–698.
Bailey GS, Williams DE, Hendricks JD (1996) Fish models for environmental carcinogenesis: the rainbow trout. Environ Health Perspect 104 (Suppl 1):5–21.
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
Beckwith LG, Moore JL, Tsao-Wu GS et al (2000) Ethylnitrosourea induces neoplasia in zebrafish (Danio rerio). Lab Invest 80:379–385.
Berghmans S, Murphey RD, Wienholds E et al (2005) tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Natl Acad Sci USA 102:407–412.
Buendia MA (2000) Genetics of hepatocellular carcinoma. Semin Cancer Biol. 10:185–200
Chen J, Jette C, Kanki JP et al (2007) NOTCH1-induced T-cell leukemia in transgenic zebrafish. Leukemia 21:462–471.
Downward J (2003) Targeting ras signalling pathways in cancer therapy. Nat Rev Cancer 3:11–22
Driever W, Solnica-Krezel L, Schier AF et al (1996) A genetic screen for mutations affecting embryogenesis in zebrafish. Development 123:37–46.
Emelyanov A, Parinov S (2008) Mifepristone-inducible LexPR system to drive and control gene expression in transgenic zebrafish. Dev Biol 320:113–121
Emelyanov A, Gao Y, Naqvi NI, Parinov S (2006) Trans-kingdom transposition of the maize dissociation element. Genetics 174:1095–1104.
Esquela-Kerscher A, Slack FJ (2006) Oncomirs–microRNAs with a role in cancer. Nat Rev Cancer 6:259–269.
Faucherre A, Taylor GS, Overvoorde J et al (2008) Zebrafish pten genes have overlapping and non-redundant functions in tumorigenesis and embryonic development. Oncogene 27:1079–1086.
Feng H, Langenau DM, Madge JA et al (2007) Heat-shock induction of T-cell lymphoma/leukemia in conditional Cre/lox-regulated transgenic zebrafish. Br J Haematol 138:169–175.
Geiger GA, Fu W, Kao GD (2008) Temozolomide-mediated radiosensitization of human glioma cells in a zebrafish embryonic system. Cancer Res 68:3396–3404.
Gong Z, Ju B, Wan H (2001) Green fluorescent protein (GFP) transgenic fish and their applications. Genetica 111:213–225.
Haffter P, Granato M, Brand M et al (1996) The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 123:1–36.
Halstead BW, Chitwood MJ and Modglin FR (1955) The anatomy of the venom apparatus of the zebrafish, Pterois volitans (linnaeus). Anat Rec 122:317–333.
Haramis AP, Hurlstone A, van der Velden Y et al (2006) Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. EMBO Rep 7:444–449.
Hawkins WE, Overstreet RM, Fournie JW, Walker WW (1985) Development of aquarium fish models for environmental carcinogenesis: tumor induction in seven species. J Appl Toxicol 5:261–264.
Hawkins WE, Walker WW, Overstreet RM (1995) Carcinogenicity tests using aquarium fish. Toxicol Methods 5:225–263.
Hendricks JD, Sinnhuber RO, Loveland PM (1980) Hepatocarcinogenicity of glandless cottonseeds and cottonseed oil to rainbow trout (Salmo gairdnerii). Science 208:309–311.
Her GM, Chiang C-C, Chen W-Y, Wu J-L (2003) In vivo studies of liver-type fatty acid binding protein (L-FABP) gene expression in liver of transgenic zebrafish (Danio rerio). FEBS Lett 538:125–133.
’t Hoen PA, Ariyurek Y, Thygesen HH et al (2008) Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms. Nucleic Acids Res 36:e141.
Jain M, Arvanitis C, Chu K et al (2002) Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 297:102–104.
Kaposi-Novak P, Libbrecht L, Woo HG et al (2009) Central role of c-Myc during malignant conversion in human hepatocarcinogenesis. Cancer Res 69:2775–2782.
Kawakami K, Takeda H, Kawakami N et al (2004) A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish. Dev Cell 7:133–144.
Krause MK, Rhodes LD, Van Beneden RJ (1997) Cloning of the p53 tumor suppressor gene from the Japanese medaka (Oryzias latipes) and evaluation of mutational hotspots in MNNG-exposed fish. Gene 189:101–106.
Lam SH and Gong Z (2006) Modeling liver cancer using zebrafish: a comparative oncogenomics approach. Cell Cycle 5:573–577.
Lam SH and Gong Z (2009) Model organisms for human disorders: fish. In: Vogel F, Motulsky AG, Antonarakis S, Speicher M (eds) Human genetics – principles and approaches, 3rd edn. Springer, Heidelberg.
Lam SH, Wu YL, Vega VB et al (2006) Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat Biotechnol 24:73–75.
Langenau DM, Feng H, Berghmans S et al (2005a) Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 102:6068–6073.
Langenau DM, Jette C, Berghmans S et al (2005b) Suppression of apoptosis by bcl-2 overexpression in lymphoid cells of transgenic zebrafish. Blood 105:3278–3285.
Langenau DM, Keefe MD, Storer NY et al (2007) Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev 21:1382–1395.
Langenau DM, Traver D, Ferrando AA et al (2003) Myc-induced T cell leukemia in transgenic zebrafish. Science 299:887–890.
Le X, Langenau DM, Keefe MD et al (2007) Heat shock-inducible Cre/Lox approaches to induce diverse types of tumors and hyperplasia in transgenic zebrafish. Genes Dev 21:1382–1395.
Lee J-S, Chu I-S, Mikaelyan A et al (2004) Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat Genet 36:1306–1311.
Lee LM, Seftor EA, Bonde G et al (2005) The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn 233:1560–1570.
Lu J, Getz G, Miska EA et al (2005) MicroRNA expression profiles classify human cancers. Nature 435:834–838.
MacInnes AW, Amsterdam A, Whittaker CA et al (2008) Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc Natl Acad Sci USA 105:10408–10413.
Masahito P, Aoki K, Egami N et al (1989) Life-span studies on spontaneous tumor development in the medaka (Oryzias latipes). Jpn J Cancer Res 80:1058–1065.
Masahito P, Ishikawa T, Sugano H et al (1986) Spontaneous hepatocellular carcinomas in lungfish. J Natl Cancer Inst 77:291–298.
Mizgireuv IV, Majorova IG, Gorodinskaya VM et al (2004) Carcinogenic effect of N-nitrosodimethylamine on diploid and triploid zebrafish (Danio rerio). Toxicol Pathol 32:514–518.
Mizgireuv IV, Revskoy SY (2006) Transplantable tumor lines generated in clonal zebrafish. Cancer Res 66:3120–3125.
Moore JL, Rush LM, Breneman C et al (2006) Zebrafish genomic instability mutants and cancer susceptibility. Genetics 174:585–600.
Nasevicius A, Ekker S (2000) Effective targeted gene ‘knockdown’ in zebrafish. Nat Genet 26:216–220.
North TE, Zon LI (2003) Modeling human hematopoietic and cardiovascular diseases in zebrafish. Dev Dyn 228:568–583.
Oster SK, Ho CS, Soucie EL, Penn LZ (2002) The myc oncogene: marvelously Complex. Adv Cancer Res 84:81–154.
Park SW, Davison JM, Rhee J et al (2008) Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. Gastroenterology 134:2080–2090.
Patton EE, Widlund HR, Kutok JL et al (2005) BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol 15:249–254.
Patton EE, Zon LI (2001) The art and design of genetic screens: zebrafish. Nat Rev Genet 2:956–966.
Pelengaris S, Khan M, Evan GI (2002) Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109:321–334.
Peterson RT, Link BA, Dowling JE, Schreiber SL (2000) Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc Natl Acad Sci USA 97:12965–12969.
Podsypanina K, Politi K, Beverly LJ, Varmus HE (2008) Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras. Proc Natl Acad Sci USA 105:5242–5247.
Sabaawy HE, Azuma M, Embree LJ et al (2006) TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA 103:15166–15171.
Schubbert S, Shannon K, Bollag G (2007) Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 7:295–308.
Shachaf CM, Kopelman AM, Arvanitis C et al (2004) MYC inactivation uncovers pluripotent differentiation and tumor dormancy in hepatocellular cancer. Nature 431:1112–1117.
Shepard JL, Amatruda JF, Finkelstein D et al (2007) A mutation in separase causes genome instability and increased susceptibility to epithelial cancer. Genes Dev 21:55–59.
Shepard JL, Amatruda JF, Stern HM et al (2005) A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proc Natl Acad Sci USA 102:13194–13199.
Shinozaki M, Fujimoto A, Morton DL, Hoon DS (2004) Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas. Clin Cancer Res 10:1753–1757.
Soucek L, Whitfield J, Martins CP et al (2008) Modeling Myc inhibition as a cancer therapy. Nature 455:679–683.
Spitsbergen JM, Kent ML (2003) The state of the art of the zebrafish model for toxicology and toxicologic pathology research – advantages and current limitations. Toxicol Pathol 31:62–87.
Spitsbergen JM, Tsai HW, Reddy A et al (2000a) Neoplasia in zebrafish (Danio rerio) treated with 7,12-dimethylbenz[a]anthracene by two exposure routes at different developmental stages. Toxicol Pathol 28:705–715.
Spitsbergen JM, Tsai HW, Reddy A et al (2000b) Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N'-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages. Toxicol Pathol 28:716–725.
Stanton MF (1965) Diethylnitrosamine-induced hepatic degeneration and neoplasia in the aquarium fish, Brachydanio rerio. J Natl Cancer Inst 34:117–130
Stern HM, Murphey RD, Shepard JL et al (2005) Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat Chem Biol 1:366–370.
Stoletov K, Montel V, Lester RD et al (2007) High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci USA 104:17406–17411.
Streisinger G, Walker C, Dower N et al (1981) Production of clones of homozygous diploid zebrafish (Brachydanio rerio). Nature 291:293–296.
Sweet-Cordero A, Mukherjee S, Subramanian A et al (2005) An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nat Genet 37:48–55.
Walter RB, Kazianis S (2001) Xiphophorus interspecies hybrids as genetic models of induced neoplasia. ILAR J 42:299–321.
Wellbrock C, Ogilvie L, Hedley D et al (2004) V599EB-RAF is an oncogene in melanocytes. Cancer Res 64:2338–2342.
White RM, Sessa A, Burke C et al (2008) Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2:183–189.
Wienholds E, van Eeden F, Kosters M et al (2003) Efficient target-selected mutagenesis in zebrafish. Genome Res. 13:2700–2707
Wolf H and Jackson EW (1963) Hepatomas in rainbow trout: descriptive and experimental epidemiology. Science 142:676–678.
Yang HW, Kutok JL, Lee NH et al (2004) Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish. Cancer Res 64:7256–7262.
Zhuravleva J, Paggetti J, Martin L et al (2008) MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish. Br J Haematol 143:378–382.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer New York
About this chapter
Cite this chapter
Gong, Z. et al. (2010). The Zebrafish Model for Liver Carcinogenesis. In: Wang, X., Grisham, J., Thorgeirsson, S. (eds) Molecular Genetics of Liver Neoplasia. Cancer Genetics. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6082-5_11
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6082-5_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6081-8
Online ISBN: 978-1-4419-6082-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)